Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis
about
Understanding the role of B cells in atherosclerosis: potential clinical implicationsPathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.The effect of oxidized phospholipids on phenotypic polarization and function of macrophages.B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsOrphan nuclear receptor Nur77 Inhibits Oxidized LDL-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells.Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialCirculating IgM Requires Plasma Membrane Disruption to Bind Apoptotic and Non-Apoptotic Nucleated Cells and Erythrocytes.Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable anginaAtherogenesis may involve the prooxidant and proinflammatory effects of ferryl hemoglobinDeterminants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a).Inflammaging in skin and other tissues - the roles of complement system and macrophage.Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update.Oxidized cholesteryl esters and inflammation.Lipoprotein(a) and its role in inflammation, atherosclerosis and malignancies.New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis.Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.Lipoprotein(a) in clinical practice: New perspectives from basic and translational science.A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.The NLRP3 and CASP1 gene polymorphisms are associated with developing of acute coronary syndrome: a case-control study.Increased haematopoietic activity in patients with atherosclerosis.Oxidation-specific epitopes restrain bone formation.IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
P2860
Q26991813-DB1EC4A2-C479-474A-A042-4222B463F51EQ27005956-F1624D6E-790D-462F-B905-363C62D33C43Q28537901-D9B2AEE7-CA97-4880-B7B6-19F952A8AD09Q30268532-0B2B5238-B26C-4D63-BD6E-F5F752FFC46FQ30279171-481835B2-3BF3-49A6-8CA0-41D4CA438F14Q33857831-A08E6AD3-5F3C-48A1-8A72-672F9EAE9D71Q34518372-A636BDCE-07D4-4C5A-8AC0-79DCAB5F289FQ34762092-064FADE4-35A8-47FD-8C40-27848D93AA8DQ35130714-33F7550A-824E-4377-8C43-B500EF4026BDQ35276226-AA5EE040-1984-4571-ADBE-A396AE7CA7EFQ35677438-EF6ED497-37EE-4169-B727-D2C15FF2BABCQ35789087-FE6DAA1A-0447-4665-A7C0-E176D4048724Q36739679-79EDB890-489E-45D7-9A21-F6EBA7390D6AQ36898674-D38F7AB4-06F7-405A-82BF-A6CC457E7BD8Q37163064-B458270A-B9D8-496A-90B4-79904C597613Q38213952-5C3862F5-6745-42F0-8E47-72AF038B3022Q38389141-32A9801A-86F0-4535-8836-58867A04B65BQ38658553-0F3DF72D-4A2C-4632-8FD1-4B239E74B51EQ38883470-3C4F184B-5ED7-4564-8FD9-94E471BFA970Q38966500-57C2105B-A2D5-47B8-B92F-C68D5E444C23Q44760819-23F953B1-F220-4304-9042-88B44004A54AQ46229988-6B9BBC81-521C-4E01-961D-A3A31CF98CA4Q46259874-D45F1EB2-BED3-4604-A3EE-650BCD0F0CBDQ47274864-9B2D954D-5E20-49CA-84BC-0FD484D7E01CQ47866518-2228969D-6C87-4E7F-9A0D-3E1AF4B5DD0FQ51027507-94111743-8F81-42AD-9305-3D951183D150Q51673633-38A0B5D7-4C8D-4309-9C05-FBB83A3C88E0Q55238725-D64AD93E-8691-44BF-BDBF-0AE64E18D9D6Q58766412-C5BD010F-DBB8-4D58-9A47-AE8D7227E0F7
P2860
Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Oxidation-specific epitopes an ...... plications for atherosclerosis
@ast
Oxidation-specific epitopes an ...... plications for atherosclerosis
@en
Oxidation-specific epitopes an ...... plications for atherosclerosis
@nl
type
label
Oxidation-specific epitopes an ...... plications for atherosclerosis
@ast
Oxidation-specific epitopes an ...... plications for atherosclerosis
@en
Oxidation-specific epitopes an ...... plications for atherosclerosis
@nl
prefLabel
Oxidation-specific epitopes an ...... plications for atherosclerosis
@ast
Oxidation-specific epitopes an ...... plications for atherosclerosis
@en
Oxidation-specific epitopes an ...... plications for atherosclerosis
@nl
P2860
P50
P1476
Oxidation-specific epitopes an ...... plications for atherosclerosis
@en
P2860
P304
P356
10.1016/J.COPH.2013.02.005
P407
P577
2013-04-01T00:00:00Z